Stock·NYSE·Technology
ServiceNow Inc. (NOW)
- Market cap
- $146.78B
- P/E
- 91.71
- Dividend yield
- 0.90%
- Street target
- $150.00median of 49 analysts
- 52-week range
- $81.24 $192.97
The short version
Where NOW stands today, in four lines, and what CleaRank Financial AI makes of it.
NOW at a glance
ServiceNow Inc. (NOW): Buy, 68/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($134.85 and $115.03).
- Earnings NOW beat estimates in 5 of its last 7 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $34.5M and bought $3.0M over the last 18 months.
- Valuation P/E of 91.7 against 35.1 for the Technology sector: a premium to peers (+161%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates ServiceNow Inc. (NOW) Buy, with a model score of 68/100.
Trend lifts that score the most: the price is 23.41% above its 200-day average and 5.28% above its 50-day average, and the 50-day average is 17.23% above the 200-day. Valuation weighs on it the most. The P/E of 91.71 is 161.3% above the sector median (a premium to peers), and the P/S of 10.43 is 37.2% above the sector median. The 50-day average is $134.85 and the 200-day average is $115.03. Across the past year the price fell 20.64%.
Only on CleaRank
Figures we compute ourselves from NOW's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $141.97 is 5.3% above the 50-day simple moving average of $134.85.Price above its 200-day average ›
The price is 23.4% above the 200-day simple moving average of $115.03.50-day average above the 200-day ›
The 50-day average ($134.85) is 17.2% above the 200-day average ($115.03), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 54% of its 52-week range, between $81.24 and $192.97.
NOW share price
Pick a period: each tab shows how far NOW has moved over it, to the last close.
Today's trading
Where NOW sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 91.71 is 161.3% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 10.43 is 37.2% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $1.7B on revenue of $14.7B, a net margin of 11.3%.Beat estimates in most recent reports ›
NOW beat the EPS estimate in 5 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 0.90%, or $1.27 a share a year.
Key statistics
The headline figures for NOW.
As of October 17, 2026, NOW trades at $141.97, with a market value of $146.78B, a P/E ratio of 91.71 and a dividend yield of 0.90%.
What the numbers say
CleaRank Financial AI's reading of NOW's valuation, growth and risks.
At a trailing P/E of 91.71, NOW is priced 161.3% above the Technology median of 35.1, and the peer comparison on this page calls that a premium to peers. Measured against sales, the stock trades at 10.43 times, which is 37.2% above the sector median of 7.6. Its market capitalisation stands at $146.8B.
NOW's revenue growth of 24.00% lags the sector median of 24.2% by 0.2 percentage points, so it is slightly slower. Its net margin of 11.34% and operating margin of 4.06% show how much of each sales dollar becomes profit, and its return on equity of 14.24% is above the sector median of 13.4%. On the balance sheet, debt-to-equity stands at 0.68, and the trailing dividend yield of 0.90% works out to $1.27 a share a year.
NOW reported EPS of $0.9 in its most recent earnings report, released on July 22, 2026. The figure topped the analysts' estimate by 4.65%. Despite that beat, the share price dropped 3.69% in the first session after the report.
The earnings record shows 5 beats in 7 reports, but beats have not guaranteed gains: the stock fell the next day after 1 of them. Earlier, the stock fell 17.75% after the April 22, 2026 report, a miss of 0.00%.
On a typical day the price of NOW shifts by 2.70%, the 30-day standard deviation of its daily returns. The P/E of 91.71, 161.3% above the sector median, puts NOW at a premium to peers, so weaker results would meet a higher bar. The price is 26.43% below its 52-week high of $192.97. Insiders sold $34.5M over the last 18 months and bought $3.0M, though sales of this kind are often planned in advance and say less than purchases would.
NOW against the Technology sector
How NOW compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: NOW trades at a significant premium to sector peers (+161%), suggesting market expectations for superior growth or market position.
Return vs XLK: Since May 6, 2025, NOW has lost 26.5% against a gain of 71.7% for XLK.
Performance against XLK
NOW and the Technology sector fund over the same days.
Revenue and earnings
How much NOW sells, and how much of it becomes profit.
Revenue growth: Revenue grew 20.9% in FY2025 to $13.3B, from $11.0B a year earlier.
Profit margin: The net margin was 13.2% in FY2025, up from 13.0% the year before.
Profitable: NOW earned $1.7B in FY2025.
Earnings reality check
Did NOW beat what analysts expected, and how did the stock react?
Earnings record: NOW beat the analyst estimate in 5 of the last 7 quarters.
Market reaction: The stock fell in the first session after 1 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 22, 2026after close | $0.86 | $0.90 | +4.65% | -3.69% | +21.27% |
| Apr 22, 2026after close | $0.97 | $0.97 | +0.00% | -17.75% | -13.76% |
| Oct 29, 2025after close | $0.85 | $0.96 | +12.94% | +2.52% | -3.52% |
| Jul 23, 2025after close | $0.71 | $0.82 | +15.49% | +4.16% | +2.20% |
| Apr 23, 2025after close | $0.77 | $0.81 | +5.19% | +15.49% | +17.51% |
| Jan 29, 2025after close | $0.73 | $0.73 | +0.00% | -11.44% | -10.19% |
| Oct 23, 2024after close | $0.69 | $0.74 | +7.25% | +5.39% | +4.66% |
As of October 17, 2026, NOW has beaten the analyst EPS estimate in 5 of its last 7 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on July 22, 2026, came in 4.65% above the estimate and the stock moved -3.69% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 55.5, in neutral territory.RSI above 50 ›
An RSI of 55.5 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of NOW
The score, the reasoning behind it, and what could move the price next.
The trend remains up for NOW, which trades at $141.97, above both its long-run averages: 5.28% above the 50-day average of $134.85 and 23.41% above the 200-day average of $115.03. That the 50-day average is 17.23% above the 200-day supports the move rather than working against it. In its 52-week range of $81.24 to $192.97, the price stands at 54%, and it is 26.43% below the high.
Recent gains sit against a weaker longer record: the price rose 1.54% over the past month, rose 37.51% over the past three months and fell 20.64% over the past year. Volume in the last session ran 37.3% above its average, on a day the price fell 4.44%. The 14-day RSI of 55.5 is in the neutral zone, and the MACD line is positive.
Earnings beat ›
The July 22, 2026 report beat the EPS estimate by 4.65%, and the share price fell 3.69% in the first session after it.
Source: Earnings report, July 22, 2026
Rating reaffirmed ›
Argus Research kept its Buy rating on October 7, 2026.
Source: Analyst action, Argus Research, October 7, 2026
- Keep an eye on the two closest levels: the 52-week high at $192.97 overhead, and the 20-day EMA at $138.76 underneath the price.
- The 14-day RSI is 55.5, which is neutral, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- The share price slid 3.69% in the first session after the July 22, 2026 report. Even so, NOW has beaten estimates in 5 of the last 7 reports.
NOW's uptrend depends on the price holding above its 50-day average of $134.85 and its 200-day average of $115.03. A close below the 50-day average would be the first sign of weakness. If the price pulls back, the first level it would reach is the 20-day EMA at $138.76.
NOW's next level overhead is its 52-week high of $192.97. The 14-day RSI reads 55.5, which places the stock in the neutral zone between 40 and 60.
Technical indicators
Momentum and trend for NOW, from its daily closes.
As of October 17, 2026, with NOW at $141.97, its 14-day RSI is 55.5 (neutral territory), its 50-day simple moving average is $134.85 and its 200-day is $115.03.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What NOW moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, NOW's 1-year correlation of daily returns is +0.38 with S&P 500 (SPY), +0.34 with Nasdaq 100 (QQQ), +0.18 with Bitcoin (BTC) and +0.00 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
45 of 49 analysts rate it a buy or strong buy, 2 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $150.00 is 5.7% above the price.More buy ratings than three months ago ›
45 of 49 rate it a buy now, against 44 of 49 three months ago.
NOW Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 7, 2026 | Argus Research | Maintains | Buy |
| Oct 6, 2026 | Stifel | Maintains | Buy |
| Oct 6, 2026 | UBS | Maintains | Neutral |
| Sep 21, 2026 | Cantor Fitzgerald | Maintains | Overweight |
| Sep 11, 2026 | Needham | Maintains | Buy |
| Sep 8, 2026 | BTIG | Maintains | Buy |
As of October 17, 2026, 49 Wall Street analysts cover NOW: 45 rate it a buy or strong buy, 2 a hold and 2 a sell or strong sell. Their 12-month price targets range from $72.00 to $248.00, with a median of $150.00, 5.7% above the price of $141.97.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
NOW trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from NOW's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much NOW tends to move, against the market and on its own.
The long record
NOW's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 2.70% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 61.8%, from January 2025 to May 2026; the price is still 37.8% below that peak.Most 1-year holds ended higher ›
76% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $95,103, against $42,055 in the S&P 500 (SPY).
NOW Drawdowns & Recovery
As of October 17, 2026, NOW's worst peak-to-trough fall over the last 10 years with dividends reinvested was -61.8% (January 2025 to May 2026); it is still 37.8% below that peak, and 76% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into NOW in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: NOW beat the S&P 500 over this period: $95,103 against $42,055.
A $10,000 investment in NOW in October 2016 would be worth about $95,103 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to NOW, and which have not.
Strongest month, May: an average of +9.25%, up in 7 of 10 years.
Weakest month, February: an average of -2.55%, up in 6 of 10 years.
This month, October: has averaged +2.72%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, NOW's strongest calendar month has been May (average +9.25%, up in 7 of 10 years) and its weakest February (average -2.55%, up in 6 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in NOW, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in NOW today could grow to about $28,220 by 2036 in the base case, with a 90th-percentile outcome near $152,418 and a 10th-percentile outcome around $5,225. The simulation models price only; at today's 0.90% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
NOW Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $215 for NOW by 2030 in the base case, from $142 today (1.5x over 4 years). The 10th-percentile path ends near $73.99. These are outcomes of a Monte Carlo simulation run on NOW's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $92.39 | $157 | $268 | |
| 2028 | $82.17 | $175 | $371 | |
| 2029 | $76.94 | $194 | $488 | |
| 2030 | $73.99 | $215 | $625 | |
| 2031 | $72.36 | $238 | $786 |
Method: a lognormal simulation of NOW's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
NOW insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $3.0M on the open market and sold $34.5M.
As of October 17, 2026, NOW insiders reported 64 open-market sales worth $34.5M and 1 open-market purchase worth $3.0M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Paul G. Fipps
Officer
|
Sell | 2.0K | $300.8K |
| Aug 28, 2026 | Jacqueline P Canney
Officer
|
Sell | 7.8K | $1.1M |
| Aug 27, 2026 | Paul Edward Chamberlain
Director
|
Sell | 2.7K | $365.9K |
| Aug 17, 2026 | Jacqueline P Canney
Officer
|
Grant | 970 | - |
| Aug 17, 2026 | Paul G. Fipps
Officer
|
Grant | 640 | - |
| Aug 17, 2026 | Danielle Fontaine
Officer
|
Grant | 485 | - |
| Aug 17, 2026 | Gina Mastantuono
President
|
Grant | 1.6K | - |
| Aug 17, 2026 | William R Mcdermott
Chief Executive Officer
|
Grant | 4.2K | - |
| Aug 14, 2026 | Jacqueline P Canney
Officer
|
Grant | 5.1K | - |
| Aug 14, 2026 | Paul G. Fipps
Officer
|
Grant | 7.7K | - |
| Aug 14, 2026 | Danielle Fontaine
Officer
|
Grant | 975 | - |
| Aug 14, 2026 | Gina Mastantuono
President
|
Grant | 8.0K | - |
| Aug 14, 2026 | William R Mcdermott
Chief Executive Officer
|
Grant | 15.2K | - |
| Aug 14, 2026 | Hossein Nowbar
President
|
Grant | 5.1K | - |
| Aug 14, 2026 | Amit Zavery
President
|
Grant | 10.3K | - |
| Aug 13, 2026 | Paul Edward Chamberlain
Director
|
Sell | 1.5K | $188.4K |
| Aug 7, 2026 | Jacqueline P Canney
Officer
|
Grant | 2.6K | - |
| Aug 7, 2026 | Paul G. Fipps
Officer
|
Grant | 5.4K | - |
| Aug 7, 2026 | Danielle Fontaine
President
|
Grant | 305 | - |
| Aug 7, 2026 | Gina Mastantuono
Chief Executive Officer
|
Grant | 3.9K | - |
| Aug 7, 2026 | William R Mcdermott
Chief Executive Officer
|
Grant | 8.8K | - |
| Aug 7, 2026 | Amit Zavery
President
|
Grant | 10.0K | - |
| Jun 15, 2026 | Eric S. Yuan
Director
|
Grant | 2.7K | - |
| May 28, 2026 | Teresa Briggs
Director
|
Sell | 1.6K | $173.4K |
| May 21, 2026 | Susan L Bostrom
Director
|
Grant | 3.3K | - |
| May 21, 2026 | Teresa Briggs
Director
|
Grant | 3.3K | - |
| May 21, 2026 | Paul Edward Chamberlain
Director
|
Grant | 3.3K | - |
| May 21, 2026 | Lawrence Jackson
Director
|
Grant | 3.3K | - |
| May 21, 2026 | Frederic B Luddy
Director
|
Grant | 3.3K | - |
| May 21, 2026 | Larry Quinlan
Director
|
Grant | 3.3K | - |
| May 21, 2026 | Anita M Sands
Director
|
Grant | 3.3K | - |
| May 18, 2026 | Paul G. Fipps
Officer
|
Sell | 1.0K | $103.2K |
| May 15, 2026 | Jacqueline P Canney
Officer
|
Grant | 6.0K | - |
| May 15, 2026 | Paul G. Fipps
Officer
|
Grant | 8.3K | - |
| May 15, 2026 | Danielle Fontaine
Officer
|
Grant | 1.5K | - |
| May 15, 2026 | Gina Mastantuono
President
|
Grant | 9.5K | - |
| May 15, 2026 | William R Mcdermott
Chief Executive Officer
|
Grant | 19.3K | - |
| May 15, 2026 | Hossein Nowbar
President
|
Grant | 5.1K | - |
| May 15, 2026 | Amit Zavery
President
|
Grant | 10.3K | - |
| May 14, 2026 | Anita M Sands
Director
|
Sell | 16.4K | $1.5M |
| May 14, 2026 | Paul Edward Chamberlain
Director
|
Sell | 1.5K | $130.8K |
| May 8, 2026 | Paul G. Fipps
Officer
|
Sell | 151 | $13.7K |
| May 7, 2026 | Jacqueline P Canney
Officer
|
Grant | 2.6K | - |
| May 7, 2026 | Paul Fipps
Officer
|
Grant | 390 | - |
| May 7, 2026 | Gina Mastantuono
Chief Executive Officer
|
Grant | 3.9K | - |
| May 7, 2026 | William R Mcdermott
Chief Executive Officer
|
Grant | 8.8K | - |
| May 7, 2026 | Amit Zavery
President
|
Grant | 10.0K | - |
| Apr 24, 2026 | Jacqueline P Canney
Officer
|
Sell | 8.9K | $799.9K |
| Feb 27, 2026 | William R Mcdermott
Chief Executive Officer
|
Buy | 28.7K | $3.0M |
| Feb 23, 2026 | Paul Fipps
Officer
|
Sell | 3.7K | $376.1K |
| Feb 18, 2026 | Paul Fipps
Officer
|
Sell | 9.6K | $1.0M |
| Feb 17, 2026 | Jacqueline P Canney
Officer
|
Grant | 28.0K | - |
| Feb 17, 2026 | Paul Fipps
Officer
|
Grant | 10.1K | - |
| Feb 17, 2026 | Gina Mastantuono
Chief Executive Officer
|
Grant | 46.0K | - |
| Feb 17, 2026 | Kevin Thomas Mcbride
Officer
|
Grant | 6.8K | - |
| Feb 17, 2026 | William R Mcdermott
Chief Executive Officer
|
Grant | 120.0K | - |
| Feb 13, 2026 | Kevin Thomas Mcbride
Officer
|
Sell | 1.4K | $148.0K |
| Feb 13, 2026 | Jacqueline P Canney
Officer
|
Grant | 1.5K | - |
| Feb 13, 2026 | Paul Fipps
Officer
|
Grant | 12.6K | - |
| Feb 13, 2026 | Paul Fipps
Officer
|
Grant | 2.1K | - |
| Feb 13, 2026 | Gina Mastantuono
President
|
Grant | 2.4K | - |
| Feb 13, 2026 | Kevin Thomas Mcbride
Officer
|
Grant | 2.5K | - |
| Feb 13, 2026 | William R Mcdermott
Chief Executive Officer
|
Grant | 6.3K | - |
| Feb 13, 2026 | Hossein Nowbar
President
|
Grant | 2.9K | - |
| Feb 13, 2026 | Amit Zavery
President
|
Grant | 3.1K | - |
| Feb 12, 2026 | Paul Edward Chamberlain
Director
|
Sell | 1.5K | $151.8K |
| Feb 12, 2026 | Jacqueline P Canney
Officer
|
Grant | 685 | - |
| Feb 12, 2026 | Paul Fipps
Officer
|
Grant | 205 | - |
| Feb 12, 2026 | Gina Mastantuono
President
|
Grant | 1.1K | - |
| Feb 12, 2026 | William R Mcdermott
Chief Executive Officer
|
Grant | 3.0K | - |
| Feb 6, 2026 | Jacqueline P Canney
Officer
|
Grant | 14.6K | - |
| Feb 6, 2026 | Russell S. Elmer
General Counsel
|
Grant | 11.5K | - |
| Feb 6, 2026 | Paul Fipps
Officer
|
Grant | 4.2K | - |
| Feb 6, 2026 | Gina Mastantuono
President
|
Grant | 22.0K | - |
| Feb 6, 2026 | Kevin Thomas Mcbride
Officer
|
Grant | 3.1K | - |
| Feb 6, 2026 | William R Mcdermott
Chief Executive Officer
|
Grant | 48.8K | - |
| Feb 6, 2026 | Nicholas Tzitzon
Officer
|
Grant | 12.2K | - |
| Feb 6, 2026 | Amit Zavery
President
|
Grant | 41.1K | - |
| Dec 5, 2025 | Gina Mastantuono
President
|
Sell | 415 | $352.8K |
| Nov 28, 2025 | Gina Mastantuono
President
|
Sell | 417 | $336.9K |
| Nov 28, 2025 | Paul Edward Chamberlain
Director
|
Sell | 300 | $242.4K |
| Nov 28, 2025 | Lawrence Jackson
Director
|
Sell | 265 | $214.7K |
| Nov 18, 2025 | Nicholas Tzitzon
Officer
|
Sell | 522 | $431.7K |
| Nov 18, 2025 | Paul Fipps
Officer
|
Sell | 305 | $249.4K |
| Nov 18, 2025 | Jacqueline P Canney
Officer
|
Sell | 239 | $200.5K |
| Nov 18, 2025 | Russell S. Elmer
General Counsel
|
Sell | 191 | $160.2K |
| Nov 17, 2025 | Jacqueline P Canney
Officer
|
Grant | 194 | - |
| Nov 17, 2025 | Russell S. Elmer
General Counsel
|
Grant | 177 | - |
| Nov 17, 2025 | Paul Fipps
Officer
|
Grant | 127 | - |
| Nov 17, 2025 | Gina Mastantuono
President
|
Grant | 319 | - |
| Nov 17, 2025 | Kevin Thomas Mcbride
Officer
|
Grant | 48 | - |
| Nov 17, 2025 | William R Mcdermott
Chief Executive Officer
|
Grant | 832 | - |
| Nov 17, 2025 | Nicholas Tzitzon
Officer
|
Grant | 166 | - |
| Nov 14, 2025 | Kevin Thomas Mcbride
Officer
|
Sell | 280 | $235.9K |
| Nov 14, 2025 | Jacqueline P Canney
Officer
|
Grant | 298 | - |
| Nov 14, 2025 | Russell S. Elmer
General Counsel
|
Grant | 239 | - |
| Nov 14, 2025 | Paul Fipps
Officer
|
Grant | 409 | - |
| Nov 14, 2025 | Gina Mastantuono
President
|
Grant | 470 | - |
| Nov 14, 2025 | Kevin Thomas Mcbride
Officer
|
Grant | 63 | - |
| Nov 14, 2025 | William R Mcdermott
Chief Executive Officer
|
Grant | 1.3K | - |
| Nov 14, 2025 | Nicholas Tzitzon
Officer
|
Grant | 298 | - |
| Nov 14, 2025 | Amit Zavery
President
|
Grant | 628 | - |
| Nov 13, 2025 | Jacqueline P Canney
Officer
|
Sell | 66 | $56.3K |
| Nov 13, 2025 | Russell S. Elmer
General Counsel
|
Sell | 62 | $52.8K |
| Nov 13, 2025 | Frederic B Luddy
Director
|
Grant | 3.5K | - |
| Nov 12, 2025 | Jacqueline P Canney
Officer
|
Grant | 136 | - |
| Nov 12, 2025 | Russell S. Elmer
General Counsel
|
Grant | 136 | - |
| Nov 12, 2025 | Paul Fipps
Officer
|
Grant | 41 | - |
| Nov 12, 2025 | Gina Mastantuono
President
|
Grant | 227 | - |
| Nov 12, 2025 | William R Mcdermott
Chief Executive Officer
|
Grant | 600 | - |
| Nov 12, 2025 | Nicholas Tzitzon
Officer
|
Grant | 114 | - |
| Nov 10, 2025 | Jacqueline P Canney
Officer
|
Sell | 257 | $222.0K |
| Nov 10, 2025 | Russell S. Elmer
General Counsel
|
Sell | 191 | $165.0K |
| Nov 7, 2025 | Jacqueline P Canney
Officer
|
Grant | 526 | - |
| Nov 7, 2025 | Russell S. Elmer
General Counsel
|
Grant | 415 | - |
| Nov 7, 2025 | Paul Fipps
Officer
|
Grant | 78 | - |
| Nov 7, 2025 | Gina Mastantuono
President
|
Grant | 789 | - |
| Nov 7, 2025 | Kevin Thomas Mcbride
Officer
|
Grant | 532 | - |
| Nov 7, 2025 | William R Mcdermott
Chief Executive Officer
|
Grant | 1.8K | - |
| Nov 7, 2025 | Nicholas Tzitzon
Officer
|
Grant | 438 | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.